---
title: "Kissei Launches Yselty in Japan, Expanding Global Uterine Fibroid Treatment Portfolio"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279700044.md"
description: "Kissei Launches Yselty in Japan, Expanding Global Uterine Fibroid Treatment Portfolio"
datetime: "2026-03-19T01:22:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279700044.md)
  - [en](https://longbridge.com/en/news/279700044.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279700044.md)
---

# Kissei Launches Yselty in Japan, Expanding Global Uterine Fibroid Treatment Portfolio

Kissei Launches Yselty in Japan, Expanding Global Uterine Fibroid Treatment Portfolio

### Related Stocks

- [4547.JP](https://longbridge.com/en/quote/4547.JP.md)

## Related News & Research

- [ADVISORY-Incorrectly tagged Kissei alert withdrawn](https://longbridge.com/en/news/286617469.md)
- [Amgen Japanese Partner Urges Caution On Tavneos Use](https://longbridge.com/en/news/286794592.md)
- [Amgen's rare disease drug linked to deaths, liver injuries in Japan, Kissei reports](https://longbridge.com/en/news/286614551.md)
- [Kissei Pharmaceutical Swings to Operating Loss but Lifts Payouts and Eyes Profit Recovery](https://longbridge.com/en/news/285902787.md)
- [11:05 ETThe Church of Jesus Christ of Latter-day Saints Commits $25 Million to the UNICEF-led Child Nutrition Fund](https://longbridge.com/en/news/287088476.md)